PRESS RELEASE

Cambridge, Mass. September 1, 2017

Manus Bio is awarded a Phase II SBIR Grant from the National Science Foundation to continue development of a low-cost production platform for a potent natural acaricide

Manus Bio announced today that it has been awarded the second phase of the National Science Foundation grant under the America's Seed Fund program. This Phase II award ($600,000) acknowledges the significant progress attained in the first phase and will continue to support the development of an advanced fermentation process for the economical and sustainable production of a highly potent natural acaricide. The full project abstract can be found at https://www.nsf.gov/awardsearch/showAward?AWD_ID=1738463.


About America’s Seed Fund

America’s Seed Fund powered by the National Science Foundation (NSF) awards nearly $190 million annually to startups and small businesses, transforming scientific discovery into products and services with commercial and societal impact. Startups working across almost all areas of science and technology can receive up to $1.5 million in non-dilutive funds to support research and development (R&D),helping de-risk technology for commercial success. America’s Seed Fund is congressionally mandated through the Small Business Innovation Research (SBIR) program. The NSF is an independent federal agency with a budget of about $7.5 billion that supports fundamental research and education across all fields of science and engineering. For more information, visit seedfund.nsf.gov.

Manus Bio leverages rapid advances in Biology to produce complex natural ingredients used in our daily lives as flavors, fragrances, food ingredients, cosmetics, vitamins, pharmaceuticals and agricultural chemicals. Using its advanced fermentation technology, Manus Bio recreates natural processes for next-generation industrial biomanufacturing and provides sustainable and cost-effective sources of ingredients for health, wellness, and nutrition. To learn more, visit www.manusbio.com.